|
PF-35574 |
CEFIXIME Advanced 200 mg Tabletas Recubiertas simples |
2010-07-07 |
|
Advanced Remedies Pvt Ltd. |
India
|
Genova Lab |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-35680 |
AMLODIPINE Y LISINOPRIL Advanced Remedies Put Ltd |
2010-07-20 |
|
Advanced Remedies Pvt Ltd. |
India
|
Genova Lab |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-35867 |
CICLOSPORINA Advanced 100 mg capsulas de gelatina suave |
2010-08-22 |
|
Advanced Remedies Pvt Ltd. |
India
|
Genova Lab |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-35916 |
CEFTRIAXONE Advenced Remedies 1 g Liofilizado p/uso Parenteral |
2010-08-26 |
|
Advanced Remedies Pvt Ltd. |
India
|
Genova Lab |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-36203 |
CEFOTAXIME Advanced 1 g liofilizado para uso parenteral |
2010-10-10 |
|
Advanced Remedies Pvt Ltd. |
India
|
Genova Lab |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-60105 |
CAPILEX 5% Espuma en aerosol |
2026-09-27 |
|
Lafage |
Argentina
|
Lafage |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-52090 |
AirFluSal Forspiro 50/500 Polvo para inhalación oral |
2025-11-03 |
|
Sandoz GmbH |
Alemania
|
Farmalogsa |
Amicelco |
Novartis Farmacéutica, Sociedad Anónima (América Central) |
Centro Distribuidor, Sociedad Anónima |
Mefasa |
Norvanda Healthcare, Sociedad Anónima |
Agefinsa |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-52091 |
AirFluSal Forspiro 50/250 Polvo para inhalación oral |
2026-05-12 |
|
Sandoz GmbH |
Alemania
|
Farmalogsa |
Amicelco |
Novartis Farmacéutica, Sociedad Anónima (América Central) |
Centro Distribuidor, Sociedad Anónima |
Mefasa |
Norvanda Healthcare, Sociedad Anónima |
Agefinsa |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-58458 |
SALBUTAMOL Novartis Access 100 mcg /Inhalación Suspensión Presurizada |
2025-08-11 |
|
Sandoz GmbH |
Alemania
|
Novartis Farmacéutica, Sociedad Anónima (América Central) |
Droguería Colón |
Norvanda Healthcare, Sociedad Anónima |
Bodega Farmacéutica, S.A. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-35915 |
DOROXAN 1 % Espuma tópica |
2010-08-26 |
|
Rottapharm S.p.A. |
Italia
|
Amicelco |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|